Omnicell to Acquire Pharmaceutical Strategy Group’s 340B Link Business
Posted on August 2, 2020
Plano, Texas – Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has entered into a definitive agreement with Pharmaceutical Strategies Group (PSG) to acquire its 340B Link business. You’ll find all the details at omnicell.com.